HER2-positive breast cancer patients receiving trastuzumab treatment obtain prognosis comparable with that of HER2-negative breast cancer patients

PURPOSE: The efficacy of trastuzumab in Chinese breast cancer (BC) patients has rarely been reported. This study was designed to compare the clinical outcomes of HER2-positive BC patients receiving or not receiving trastuzumab treatment and HER2-negative BC patients. PATIENTS AND METHODS: This study...

Descripción completa

Detalles Bibliográficos
Autores principales: Qin, Tao, Yuan, Zhongyu, Peng, Roujun, Bai, Bing, Shi, Yanxia, Teng, Xiaoyu, Liu, Donggeng, Wang, Shusen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2013
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3626365/
https://www.ncbi.nlm.nih.gov/pubmed/23630425
http://dx.doi.org/10.2147/OTT.S40851

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3626365/
https://www.ncbi.nlm.nih.gov/pubmed/23630425
http://dx.doi.org/10.2147/OTT.S40851

Ejemplares similares